Additionally, FRα -specific cytotoxic T lymphocytes (CTL) were detected in malignant ascites [12, 13] as well as peripheral blood [14] of ovarian cancer patients, thus indicating that FRα peptides are immunogenic in vivo. The gene discussed is FOLR1; the disease is ovarian cancer.